Myeloid neoplasms with eosinophilia

A Reiter, J Gotlib - Blood, The Journal of the American Society …, 2017 - ashpublications.org
Molecular diagnostics has generated substantial dividends in dissecting the genetic basis of
myeloid neoplasms with eosinophilia. The family of diseases generated by dysregulated …

JAK/STAT signaling in hematological malignancies

W Vainchenker, SN Constantinescu - Oncogene, 2013 - nature.com
The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is
central to signaling by cytokine receptors, a superfamily of more than 30 transmembrane …

A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

R Kralovics, F Passamonti, AS Buser… - … England Journal of …, 2005 - Mass Medical Soc
Background Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are
clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of …

[HTML][HTML] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

RL Levine, M Wadleigh, J Cools, BL Ebert, G Wernig… - Cancer cell, 2005 - cell.com
Polycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with
myelofibrosis (MMM) are clonal disorders arising from hematopoietic progenitors. An …

Biology and significance of the JAK/STAT signalling pathways

H Kiu, SE Nicholson - Growth factors, 2012 - Taylor & Francis
Since its discovery two decades ago, the activation of the Janus kinase/signal transducers
and activators of transcription (JAK/STAT) pathway by numerous cytokines and growth …

STATs in oncogenesis

T Bowman, R Garcia, J Turkson, R Jove - Oncogene, 2000 - nature.com
Since their discovery as key mediators of cytokine signaling, considerable progress has
been made in defining the structure-function relationships of Signal Transducers and …

JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

LM Scott, W Tong, RL Levine, MA Scott… - … England Journal of …, 2007 - Mass Medical Soc
Background The V617F mutation, which causes the substitution of phenylalanine for valine
at position 617 of the Janus kinase (JAK) 2 gene (JAK2), is often present in patients with …

Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl

E Weisberg, PW Manley, W Breitenstein, J Brüggen… - Cancer cell, 2005 - cell.com
Summary The Bcr-Abl tyrosine kinase oncogene causes chronic myelogenous leukemia
(CML) and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) …

A Tyrosine Kinase Created by Fusion of the PDGFRA and FIP1L1 Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome

J Cools, DJ DeAngelo, J Gotlib, EH Stover… - … England Journal of …, 2003 - Mass Medical Soc
Background Idiopathic hypereosinophilic syndrome involves a prolonged state of
eosinophilia associated with organ dysfunction. It is of unknown cause. Recent reports of …

Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells

RS Ohgami, DR Campagna, EL Greer, B Antiochos… - Nature …, 2005 - nature.com
The reduction of iron is an essential step in the transferrin (Tf) cycle, which is the dominant
pathway for iron uptake by red blood cell precursors. A deficiency in iron acquisition by red …